BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Laser capture microdissection
,
Fenofibrate
,
rs2300478
,
VEGFA
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sphingosine 1- phosphate
Summary
General Info
Curated Studies
Most Correlated Studies
Cardiac myocytes from IPSCs sparsely plated and treated with XMU-MP-1 and sphingosine-1-phosphate
Fibrotic and immune pathway signatures in dermal fibroblasts
Sphingosine-1-phosphate (S1P) effects on U373 MG glioblastoma cells compared to EGF in vitro
Brain astrocytoma 1321N1 cells with YAP or MRTFA or RHOA knockout and with sphingosine 1-phosphate
Breast cancer MCF7 cells treated with sphingosine-1-phosphate, FTY720 or SAHA
Explore Curated Studies Results
Literature
Most Relevant Literature
Cardiovascular effects of sphingosine-1-phosphate (S1P).
Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases.
Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases.
Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis.
Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosin…
Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-…
Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Rec…
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients Wi…
Serum Sphingolipidomic Analyses in Healthy, Diabetic and Prediabetic Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ